(2R)-4-[(Benzyloxy)carbonyl]-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-2-piperazinecarboxylic acid(CAS: 138775-02-7)

The compound must comply with the REACH regulations in the European Union, ensuring that manufacturers and importers register substances above a certain tonnage threshold. Additionally, it should adhere to the Globally Harmonized System (GHS) for classification and labeling of chemicals, including appropriate hazard communication. In the United States, it must meet FDA and EPA requirements, focusing on safe handling, storage, and disposal to protect human health and the environment.

There are alternative reagents, such as (2S)-4-[(Benzyloxy)carbonyl]-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-2-piperazinecarboxylic acid or other piperazine derivatives, which can be used as alternatives in synthesis. These alternatives may offer similar functionality but with different reactivity and selectivity, providing flexibility in the design of synthetic routes.

There is a growing interest in the compound for its potential in drug discovery and development, particularly in the field of kinase inhibitors. Market trends indicate increasing research and development efforts, driven by its structural complexity and biological activity. Price trends suggest stability, but fluctuations may occur based on supply and demand dynamics.

Waste containing this compound should be collected and disposed of according to local regulations. It is advisable to incinerate the waste at a licensed facility to ensure complete destruction. Environmental protection precautions include proper containment during collection and transportation to prevent spillage. Additionally, the waste should be minimized through efficient use and recycling, where applicable, to reduce overall environmental impact.